Home > Partnering

Acquisition & In-Licensing

Strategic in-licensing and acquisitions have been fundamental to our success and will continue to drive our growth at Merus Labs. We are actively seeking new specialty pharmaceutical products in addition to continuing acquisitions of legacy products in order to strengthen our portfolio.

While we have a strong presence in Cardiovascular and Women’s Health markets, we are actively looking for prescription products in additional therapeutic areas such as Urology, CNS, Oncology Support, Dermatology, Ophthalmology, Nephrology, and Anti-Infectives. Of most interest are specialty products that are either approved or have been submitted for regulatory approval.


Merus Labs is seeking out-licensing partners for certain products in territories where we possess the rights but do not currently commercialize.

Contact Info

  • Paul Pay
    Chief Business Development Officer